Literature DB >> 16259889

Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass.

Cristiane M Moulin de Moraes1, Marcio C Mancini, Maria Edna de Melo, Daniela Andraus Figueiredo, Sandra Mara F Villares, Alessandra Rascovski, Bruno Zilberstein, Alfredo Halpern.   

Abstract

BACKGROUND: There are many studies concerning thyroid function in obesity, and some of them describe higher TSH levels in obese subjects. Few studies evaluated long-term changes in thyroid function caused by weight loss after bariatric surgery. Our aims were to evaluate the prevalence of subclinical hypothyroidism (SH) in a morbidly obese population and to analyze the effect of weight loss induced by Roux-en-Y gastric bypass (RYGBP) on TSH and thyroid hormone (TH) levels.
METHODS: TSH, free thyroxine (fT4) and total triiodothyronine (T3) levels were analyzed before and 12 months after RYGBP in patients with grade III or grade II obesity with co-morbidities. Subjects taking TH and/or with positive antithyroid antibodies and/or with overt hypothyroidism were excluded.
RESULTS: 72 subjects (62F/10M), with mean age 39.6+/-9.8 years and mean BMI 53.0+/-10.4 kg/m2 were studied. The prevalence of SH before RYGBP was 25% (n=18). There was a significant post-surgical decrease in BMI in the whole population, as well as in SH patients. In the SH group and normal TSH group, there was a decrease in TSH and T3, but not in fT4. TSH was not correlated with initial BMI or percent change in BMI. TSH concentrations reached normal values in all SH patients after RYGBP.
CONCLUSION: Our data confirm that severe obesity is associated with increased TSH. The decrease in TSH was independent of BMI, but occurred in all SH patients. A putative effect of weight reduction on the improvement of SH in all patients may be an additional benefit of bariatric surgery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16259889     DOI: 10.1381/096089205774512537

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  32 in total

1.  Defining the role of bariatric surgery in polycystic ovarian syndrome patients.

Authors:  Shaveta M Malik; Michael L Traub
Journal:  World J Diabetes       Date:  2012-04-15

2.  TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Stefania Camastra; Ugo Politti; Ilaria Ruffilli; Roberto Vita; Giuseppe Navarra; Salvatore Benvenga; Alessandro Antonelli
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

3.  Reduction in Thyroid-Stimulating Hormone Correlated with Improved Inflammation Markers in Chinese Patients with Morbid Obesity Undergoing Laparoscopic Sleeve Gastrectomy.

Authors:  Cuiling Zhu; Jingyang Gao; Fangyun Mei; Liesheng Lu; Donglei Zhou; Shen Qu
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

4.  Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters.

Authors:  Draženka Janković; Peter Wolf; Christian-Heinz Anderwald; Yvonne Winhofer; Miriam Promintzer-Schifferl; Astrid Hofer; Felix Langer; Gerhard Prager; Bernhard Ludvik; Alois Gessl; Anton Luger; Michael Krebs
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

5.  Effect of Weight Loss after Bariatric Surgery on Thyroid-Stimulating Hormone Levels in Patients with Morbid Obesity and Normal Thyroid Function.

Authors:  João Sérgio Neves; Sofia Castro Oliveira; Pedro Souteiro; Jorge Pedro; Daniela Magalhães; Vanessa Guerreiro; Rita Bettencourt-Silva; Maria Manuel Costa; Ana Cristina Santos; Joana Queirós; Ana Varela; Paula Freitas; Davide Carvalho
Journal:  Obes Surg       Date:  2018-01       Impact factor: 4.129

6.  Laparoscopic Sleeve Gastrectomy has A Positive Impact on Subclinical Hypothyroidism Among Obese Patients: A Prospective Study.

Authors:  Mohamed AbdAlla Salman; Ahmed Rabiee; Ahmed Salman; Mohamed G Qassem; Mahmoud A Ameen; Ahmed M Hassan; Ahmed Soliman; Hossam Shaaban; Ghada M K GabAllah; Ahmed A Ismail; Haitham S E Omar
Journal:  World J Surg       Date:  2021-06-26       Impact factor: 3.352

7.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Obesity (Silver Spring)       Date:  2013-03       Impact factor: 5.002

8.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Endocr Pract       Date:  2013 Mar-Apr       Impact factor: 3.443

9.  Thyroid function and insulin sensitivity before and after bilio-pancreatic diversion.

Authors:  Donatella Gniuli; Laura Leccesi; Caterina Guidone; Amerigo Iaconelli; Chiara Chiellini; Andrea Manto; Marco Castagneto; Giovanni Ghirlanda; Geltrude Mingrone
Journal:  Obes Surg       Date:  2009-11-03       Impact factor: 4.129

10.  Thyroid Hormone Changes After Sleeve Gastrectomy With and Without Antral Preservation.

Authors:  Kerem Karaman; Kaan Mansıroglu; Ozkan Subasi; Aytac Biricik; Hakan Yirgin; Elif Kose; Metin Ercan
Journal:  Obes Surg       Date:  2020-08-03       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.